Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial

by Jan Dörr, Klaus-Dieter Wernecke, Jens Würfel, Jens Würfel, Judith Bellmann-Strobl, Judith Bellmann-Strobl, Volker Siffrin, Muriel B. Sättler, Mikael Simons, Mikael Simons, Mikael Simons, Andreas Linsa, Andreas Linsa, Hayrettin Tumani, Hayrettin Tumani, Friedemann Paul, Friedemann Paul, Friedemann Paul
Published 2018-10-01